{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:27:14Z","timestamp":1773354434054,"version":"3.50.1"},"reference-count":44,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,4,21]]},"abstract":"<jats:p>In India and China, indigenous drug manufacturers market arbitrarily combined parenteral \u03b2-lactam and \u03b2-lactamase inhibitors (BL-BLIs). In these fixed-dose combinations, sulbactam or tazobactam is indiscriminately combined with parenteral cephalosporins, with BLI doses kept in ratios similar to those for the approved BL-BLIs. Such combinations have been introduced into clinical practice without mandatory drug development studies involving pharmacokinetic\/pharmacodynamic, safety, and efficacy assessments being undertaken.<\/jats:p>","DOI":"10.1128\/aac.00168-20","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T14:08:45Z","timestamp":1583244525000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Unorthodox Parenteral \u03b2-Lactam and \u03b2-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care"],"prefix":"10.1128","volume":"64","author":[{"given":"Snehal","family":"Palwe","sequence":"first","affiliation":[{"name":"SB College of Science, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hariharan","family":"Periasamy","sequence":"additional","affiliation":[{"name":"Central Leather Research Institute, University of Madras, Chennai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshama","family":"Khobragade","sequence":"additional","affiliation":[{"name":"SB College of Science, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun S.","family":"Kharat","sequence":"additional","affiliation":[{"name":"Laboratory of Applied Microbiology, Jawaharlal Nehru University, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2017.10.028"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02240"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks121"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70780-7"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-99"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-015-0009-x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204805"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.186200"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.180305"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30093-6"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30365-0"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(02)00466-2"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.020784-0"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.08.002"},{"key":"e_1_3_3_16_2","volume-title":"AMR surveillance network data. January 2018-December 2018","author":"Indian Council of Medical Research","year":"2019","unstructured":"Indian Council of Medical Research. 2019. Annual report. AMR surveillance network data. January 2018-December 2018. Indian Council of Medical Research, New Delhi, India."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00355-19"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02187-18"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0725-1"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2013\/4564.2733"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02431-18"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00833"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205166"},{"key":"e_1_3_3_24_2","first-page":"75","article-title":"Comparative in vitro activity of Zydotum against Gram negative and Gram positive clinical isolates","volume":"14","author":"Chaudhary M","year":"2015","unstructured":"Chaudhary M, Payasi A. 2015. Comparative in vitro activity of Zydotum against Gram negative and Gram positive clinical isolates. IOSR J Dent Med Sci 14:75\u201378.","journal-title":"IOSR J Dent Med Sci"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.5799\/ahinjs.02.2012.03.0049"},{"key":"e_1_3_3_26_2","first-page":"22","article-title":"Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections","volume":"60","author":"Patankar M","year":"2012","unstructured":"Patankar M, Sukumaran S, Chhibba A, Nayak U, Sequeira L. 2012. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections. J Assoc Physicians India 60:22\u201324.","journal-title":"J Assoc Physicians India"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-016-0928-7"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3923\/ejdm.2011.28.31"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01745246"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06349-11"},{"key":"e_1_3_3_31_2","unstructured":"Bhatia A Chugh R Gupta M Friedland HD Iwanowski P. 2017. Safety and pharmacokinetics of single and multiple intravenous doses of WCK 4282 (cefepime and tazobactam) in healthy volunteers. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) poster P1303."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.08.011"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02409-16"},{"key":"e_1_3_3_34_2","unstructured":"Umarkar K Kulkarni A Satav J Tayde P Takalkar S Chavan R Zope V Bhagwat S Patel M. 2017. WCK 4282 [high-dose cefepime (FEP)-tazobactam (TAZ)]: in vivo PK\/PD studies against piperacillin-tazobactam (PIP-TAZ)-resistant KPC-expressing E. cloacae and E. aerogenes and AmpC+ESBL expressing P. mirabilis and S. marcescens. ASM Microbe 2017 poster P281."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.566"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01004-09"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics3030398"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01612-17"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz373"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm001"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2001.00204.x"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.40.10.3798-3801.2002"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph7072745"},{"key":"e_1_3_3_44_2","first-page":"2569","article-title":"Pharmacokinetics and pharmacodynamics of Elores in complicated urinary tract infections caused by extended spectrum beta-lactamase strains","volume":"6","author":"Attili VSS","year":"2015","unstructured":"Attili VSS, Chaudhary M. 2015. Pharmacokinetics and pharmacodynamics of Elores in complicated urinary tract infections caused by extended spectrum beta-lactamase strains. Int J Pharm Sci Res 6:2569\u20132578.","journal-title":"Int J Pharm Sci Res"},{"key":"e_1_3_3_45_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"CLSI","year":"2018","unstructured":"CLSI. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 11th ed. CLSI Standard M07. Clinical and Laboratory Standard Institute, Wayne, PA.","edition":"11"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00168-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00168-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:50:21Z","timestamp":1645480221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00168-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,4,21]]}},"alternative-id":["10.1128\/AAC.00168-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.00168-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"assertion":[{"value":"2020-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00168-20"}}